About Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma is a rare disease catalogued by Orphanet (ORPHA:178528). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma trials.
Search ClinicalTrials.gov for "Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma" or Orphanet code ORPHA:178528 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. Updated daily.